Heart Views

REVIEW ARTICLE
Year
: 2022  |  Volume : 23  |  Issue : 1  |  Page : 1--9

Transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: A systematic review


Abdallah El Sabbagh1, Mohammed Al-Hijji2, Mayra Guerrero3 
1 Department of Cardiovascular Diseases, Mayo Clinic, Jacksonville, Florida, USA
2 Department of Adult Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar
3 Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA

Correspondence Address:
Dr. Mayra Guerrero
Department of Cardiovascular Diseases, Mayo Clinic, 200 First St Sw, Rochester, Minnesota 55905
USA

Background: Transcatheter aortic valve in valve (Aviv) replacement has been shown to be an effective therapeutic option in patients with failed aortic bioprosthetic valves. This review intended to evaluate contemporary 1-year outcomes of Aviv in recent studies. Methods: A systematic review on outcomes of Aviv was performed using the best available evidence from studies obtained using a MEDLINE, Cochrane database, and SCOPUS search. Endpoints of interest were survival, coronary artery obstruction, prosthesis-patient mismatch (PPM), stroke, pacemaker implantation, and structural valve deterioration. Results: A total of 3339 patients from 23 studies were included. Mean age was 68–80 years, 20%–50% were female, and Society of Thoracic Surgeons score ranged from 5.7 to 31.1. Thirty-day all-cause mortality ranged from 2% to 8%, and 1-year all-cause mortality ranged from 8% to 33%. Coronary artery obstruction risk after Aviv ranged from 0.6% to 4%. One-year stroke ranged from 2% to 8%. Moderate-severe PPM occurred in 11%–58%, and pacemaker rate at 1 year ranged from 5% to 12%. Conclusion: Transcatheter aortic ViV has emerged as an effective therapeutic option to treat patients with failed bioprostheses. The acceptable complication rate and favorable 1-year outcomes make Aviv an appropriate alternative to redo surgical aortic valve replacement.


How to cite this article:
Sabbagh AE, Al-Hijji M, Guerrero M. Transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: A systematic review.Heart Views 2022;23:1-9


How to cite this URL:
Sabbagh AE, Al-Hijji M, Guerrero M. Transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: A systematic review. Heart Views [serial online] 2022 [cited 2022 Jul 2 ];23:1-9
Available from: https://www.heartviews.org/article.asp?issn=1995-705X;year=2022;volume=23;issue=1;spage=1;epage=9;aulast=Sabbagh;type=0